摘要
Prolotherapy取名來自拉丁文proli-，有「生長」的意思，中文稱做「增生療法」。然而增生療法是一種泛稱，任何促進人體自行修復的方式皆可稱之，其中較廣為人知的是「增生注射治療」，有人又直接稱增生治療，是把增生劑(proliferant)注射到肌腱、韌帶等軟組織，促進修復的一種注射技術，而增生劑是指配合增生療法能夠幫助人體自我修復的物質。目前常聽到的增生劑有葡萄糖溶液(dextrose)、高濃度血小板血漿(platelet-rich plasma, PRP)、幹細胞等。相較PRP收費高昂，葡萄糖便宜又安全的特性，使得葡萄糖注射成為目前接受度最高的增生療法。關於增生注射治療的適應症，目前證據力較強的有下列病症，肱骨外上髁炎(lateral epicondylitis of the elbow)、Osgood-Schlatter disease、顳顎關節症候群(temporomandibular joint dysfunction)、膝關節炎、手指關節炎、薦髂關節疼痛(sacroiliac joint pain)。
參考文獻
2. Hauser RA, Lackner JB, Steilen-Matias D, et al. A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clin Med Insights Arthritis Musculoskelet Disord 2016;9:139-59.
4. 59 Topol GA, Podesta LA, Reeves KD, et al. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics 2011;128:e1121-8.
5. Refai H, Altahhan O, Elsharkawy R. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Sur 2011;69:2962-70.
6. Yelland MJ, Sweeting KR, Lyftogt JA, et al. Pfrolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomised trial. Br J Sports Med 2011;45:421-8..
7. Maxwell NJ, Ryan MB, Taunton JE, et al. Sonographically guided intratendinous injection of hyperosmolar dextrose to treat chronic tendinosis of the Achilles tendon: a pilot study. Am J Roentgenol 2007;189:w215-20.